Skip to content

Laser Welding

We are experts in using laser welding to join metals with precision and low-heat input to create complex components and subassemblies for medical devices. Our deep process knowledge and state-of-the-art equipment allow us to solve complex manufacturing problems and perform laser welding at a micro-scale. In addition to our decades of in-house experience, we also invest significantly in R&D projects to continually advance our capabilities. Our Lightspeed Lab process experts can help you take advantage of our laser welding technology with industry-leading prototype solutions, design feedback, and manufacturing process development.

Laser Welding Applications Include

  • Pull ring assemblies for steerable catheters
  • Marker bands
  • Flexible hypotubes
  • 3D components
  • Thin-wire delivery system components
  • Hermetic seals for implants and instruments
  • Micro implants

Laser Welding Specifications

min | max

  • Material thickness: 0.025 mm | 1 mm
  • Joint width limitations: N/A | 0.125 mm max gap
  • Depth of penetration maximum: N/A | 1 mm
  • Strength maximum: N/A | 80% of base material

Laser Welding Materials

We perform laser welding on a variety of metals, including, but not limited to:

  • Stainless steel
  • Nitinol
  • Cobalt chrome
  • Titanium
  • Precious metals
Knowledge Center
news

Resonetics® Acquires Eden Holdings, Adding Injection Molding to its Capabilities

brochure

COMING SOON: Contego® 100 mAh Battery

articles

The Power of an Integrated Nitinol Supply Chain

articles

Resonetics Celebrates 35 Years of Consistent Nitinol Melting and Processing

articles

The Benefits of Nitinol for Orthopedic Devices: Q&A with Eric Veit

whitepapers

Nitinol Post-Shape-Setting TTT & TTS Properties

news

Resonetics® Invests in Nitinol Gun Drilling Capabilities Through Purchase of Assets from Medical Component Specialists

articles

Impact of Nitinol in Medical Device Manufacturing: Q&A with Scott Robertson

articles

Ensuring Stability in the Nitinol Supply Chain: Q&A with Rich LaFond

0